Cargando…
Evaluation of the HIV drug resistance surveillance system in Mozambique, 2017-2018
In the past ten years, the prevalence of primary Human Immunodeficiency Virus (HIV) drug resistance has ranged from zero to 25%, with higher and increasing rates in countries with access to antiretroviral therapy (ART), a specific case in Mozambique. World Health Organization (WHO) recommended that...
Autores principales: | Nuvunga, Samuel, Langa, Denise Chitsondzo, Baltazar, Cynthia Semá, Sacarlal, Jahit, Rossetto, Erika, Vubil, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941613/ https://www.ncbi.nlm.nih.gov/pubmed/36825120 http://dx.doi.org/10.11604/pamj.2022.43.162.29206 |
Ejemplares similares
-
Evaluation of the multidrug-resistant tuberculosis surveillance system in Maputo City, Mozambique in the period 2017-2018
por: Balate, Dionísia Alfredo, et al.
Publicado: (2022) -
Evaluation of the Mozambique Antiretroviral Therapy (MozART) database as an antiretroviral therapy patient surveillance system, 2017-2018
por: Fataha, Neusa Vanessa Fernandes Abdul, et al.
Publicado: (2022) -
Analysis of Interview Breakoff in the Behavioral Risk Factor Surveillance System, 2018 and 2019
por: Hsia, Jason, et al.
Publicado: (2023) -
Recognizing the hidden: strengthening the HIV surveillance system among key and priority populations in Mozambique
por: Semá Baltazar, Cynthia, et al.
Publicado: (2021) -
Rapid virtual training and field deployment for COVID-19 surveillance officers: experiences from Ethiopia
por: Wang, Shu-Hua, et al.
Publicado: (2022)